Skip to main content

  • JP26-281928

    Building bridges in regenerative medicine: Japanese delegation visits the Netherlands

    From 26-28 October 2026, RegMed XB welcomed a delegation of Japanese regenerative medicine companies and startups to the Netherlands, in close collaboration with the Netherlands Enterprise Agency (RVO) and Nakanoshima Qross.

    read more
    Biohybrid Kidney XB (Crossing Borders)

    Unique Program to Develop a Biohybrid Kidney Launched

    The Biohybrid Kidney Crossing Borders (XB) research initiative officially launched this month. 

    read more
    Impact report 2025

    The RegMed XB Impact Report 2025 is now live

    For the first time, our Annual Report has a new name and a new look, introducing the Impact Report 2025.

    read more
  • Leidsch Dagblad, 26 July 2023: 1st Annual Conference

    Chemical Daily, 3 July 2025: Interview with Bernard Mulder in Japanese newspaper